• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·AVLN
Share

Avalyn Pharma Inc. Stocks

$ 31.45Last Updated 18.06.2026

Issuer Rating

Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

$ 1.39B

$ 31.45
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

03.05.2026 21:00

S&P goes after SpaceX, Uzbekistan fund to offer discount: the main thing about the IPO by Ma. 3

30.04.2026 15:00

Avalyn Pharma IPO: Novo Nordisk-backed biotech goes public

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Target Price

Favourable
6/7

The average target price of AVLN is 60 and suggests 89.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.06.2026 19:36

Iran announced the closure of the Strait of Hormuz

20.06.2026 19:01

The Economics of Emotions. Which Is Better: An Index Fund or a Han Solo LEGO Figure?

20.06.2026 16:28

Co-founder of the Assassin's Creed game developer dies in a plane crash — Le Figaro

20.06.2026 16:01

What's Happening in Small-Cap Stocks: Betting on Anthropic's IPO, Ozempic's Beneficiary, and the Biotech Rally

20.06.2026 13:01

Disputes Over Oil, SpaceX's Acquisition of an AI Startup, and Why the First Trillionaire Emerged

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026